DNSP-11_Dosage, benefits & legal status
Also known as DNSP 11, dopamine neuron stimulating peptide-11, brain excitatory peptide
A brain peptide from the GDNF precursor, studied in rats and monkeys and never in people.
Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.
What is DNSP-11?
Plain language first. The technical label stays, but it never stands alone.Overview
It is a small fragment of the precursor to a brain growth factor. It protected dopamine neurons in rats and monkeys. Nobody has given it to a person in a published study.
DNSP-11 (PPEAPAEDRSL-NH2) is an amidated 11-mer from the proGDNF domain, neurotrophic to dopaminergic neurons in vitro and in rodent models of Parkinson's disease, acting through pathways that do not appear to involve the GFR-alpha1 receptor.
What it's used for
Sold for brain and nerve research. The published work is in cells, rats and monkeys, with nothing in people.
How does DNSP-11 work?
What it does in the body, and where.DNSP-11 came out of an attempt to get GDNF's benefits in a smaller molecule.
- 01GDNF protects dopamine neuronsBut it is a large protein that distributes poorly in the brain, which is why trials of it have struggled.
- 02This 11-mer is cut from GDNF's precursorIt supported neuron survival in culture and raised dopamine levels in rat brain for up to 28 days after a single injection into the substantia nigra.
- 03The delivery problem did not go awayWork in rats and monkeys used intranasal delivery or direct brain infusion. Its short half-life makes useful brain exposure from a systemic injection unlikely.
A schematic of the compound's mechanism, not a diagnostic image.
What else is it used for?
Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.
- Protecting dopamine neurons, the cells lost in Parkinson's diseaseResearch only
- General brain and nerve repair claimsResearch only

At a glance
Four things to know about DNSP-11
Evidence
Research only
Category
Brain, mood and sleep
Common vial
5 mg
Half-life
Nothing published in humans
How much, and do you cycle it?
The range, and whether you take breaks.Research only, no established pattern. No established patternNo range
No published human study establishes a schedule.
How long does it stay in the body?
The half-life, and where the figure comes from.Nothing published in humansNo figure
You can compare this against the whole library to see where it sits.
How do I dose and price it?
Enter your vial and your dose. Pick a mix. We show the draw and the cost.The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.
Choose your mix
Measuring the water1 mL = one full 100-unit syringe.
Your draw
0 / 100 unitsDNSP-11 starts at $37.99 across 1 vendor.
1 listing, last read Sep 12, 2026. Shipping and card fees are not included.
How do you store it?
Before mixing, and after.Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.
Unmixed lyophilized DNSP-11 keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.
What are the side effects and cautions?
Known cautions and warnings for this compound.Vendor pages describing DNSP-11 as a proSAAS fragment are wrong. The published sequence comes from the GDNF precursor.
Who should avoid it
- No human safety data exists at all
- Pregnancy
Stop and get help
- Anything unusual, since there is no known safety profile
- Signs of an allergic reaction such as face or throat swelling, hives, or trouble breathing
Common effects
- Unknown in humans. Studied only in cells, rats and monkeys
Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.
Is DNSP-11 approved?
And where the numbers on this page come from.No. DNSP-11 is not approved for any use, anywhere. It is sold labelled for laboratory research only, and there is no legal route to buy it for human use.
- Approval statusResearch only
- RouteInjected in research; delivered into the brain or up the nose in the studies
- Checked24 September 2026
- DoseFrom research and community reports. No regulator has reviewed this dose.
- Vial sizeFrom what vendors typically list; not a recommendation.
- Sources
What has happened recently
Not approved anywhere. No registered human trial.
You can compare this against the whole library, or read how to check a seller.
What else is like DNSP-11?
Others in Brain, mood and sleep, side by side.If you're weighing DNSP-11, it's worth reading MIF-1, P7C3, and Semax in the same class.
A brain peptide from the GDNF precursor, studied in rats and monkeys and never in people.
- Dose
- Research only
- How often
- No established pattern
A three amino acid brain peptide tested in Parkinson's and depression in the 1970s.
- Dose
- Research only
- How often
- No established pattern
A neuroprotective molecule from a mouse screen. Never given to a person.
- Dose
- Research only
- How often
- No established pattern
A peptide used for sharper focus, memory, and mental clarity.
- Dose
- 0.2 up to 0.6 mg per day
- How often
- 1-2x daily
Guides for this compound
- How to Reconstitute a Peptide
Mix peptide powder with bacteriostatic water, step by step.
- How to Read an Insulin Syringe
Read the units, convert to millilitres, and draw the exact dose.
- mcg vs mg: The Peptide Dosing Mistake to Avoid
Your vial says mg and your protocol says mcg. Here is the conversion and how to check it.
- Why Does My Peptide Injection Itch or Welt
Injection-site irritation, a histamine reaction, or a true allergy, and how to tell them apart.
- How to Read a Peptide COA
What the purity number does and does not tell you, and how to spot an edited report.
Sources
- Bradley LH, et al. Dopamine neuron stimulating actions of a GDNF propeptide. PLoS ONE(2010)A single injection into rat substantia nigra raised dopamine and its metabolites for up to 28 days.
- Stenslik MJ, et al. Repeated intranasal delivery of DNSP-11 in a rat model of Parkinson's disease. J Neurosci Methods(2015)Intranasal dosing raised dopamine turnover in rats; brain exposure from systemic dosing is considered unlikely.
Last reviewed 24 September 2026
